A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication

European Journal of Vascular and Endovascular Surgery

Volumn 31, Issue 3, 2006, Pages 266-273

  Collins, P ^a   Ford, I ^b   Ball, D ^a   Macaulay, E ^b   Greaves, M ^b   Brittenden, J ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Platelet aggregation; sICAM; Soluble P selectin; Von Willebrand factor, exercise, intermittent claudication

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; FIBRINOGEN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; PRAVASTATIN; PROSTAGLANDIN SYNTHASE; SIMVASTATIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; TREADMILL EXERCISE; VASCULAR ENDOTHELIUM; VOLUNTEER; WALKING;

AGED; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; EXERCISE TEST; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION; VON WILLEBRAND FACTOR; WALKING;

EID: 33144465590     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.10.011     Document Type: Article

References (42)

1. G.C. Leng B. Fowler E. Ernst Exercise for intermittent claudication cochrane peripheral vascular diseases group Br J Surg 92 S1 2005 9
2. E.P. Turton P.A. Coughlin R.C. Kester D.J. Scott Exercise training reduces the acute inflammatory response associated with claudication Eur J Vasc Endovasc Surg 23 2002 309-316
3. P.V. Tisi C.P. Shearman The evidence for exercise-induced inflammation in intermittent claudication: Should we encourage patients to stop walking? Eur J Vasc Endovasc Surg 15 1998 7-17
4. K. Cassar P. Bachoo J. Brittenden The role of platelets in peripheral vascular disease Eur J Vasc Endovasc Surg 25 2003 6-15
5. K. Cassar P. Bachoo I. Ford M. Greaves J. Brittenden Platelet activation is increased in peripheral arterial disease J Vasc Surg 38 2003 99-103
6. P.A. Robless D. Okonko P. Lintott A.O. Mansfield D.P. Mikhailidis G.P. Stansby Increased platelet aggregation and activation in peripheral arterial disease Eur J Vasc Endovasc Surg 25 2003 16-22
7. M. Koksch F. Zeiger K. Wittig A. Siegemund C.B. Reininger D. Pfeiffer et. al. Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease Eur J Vasc Endovasc Surg 21 2 2001 147-154
8. C.B. Reininger J. Graf A.J. Reininger M. Spannagl B. Steckmeier L. Schweiberer Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease Thromb Res 82 6 1996 523-532
9. S.S. Signorelli M.C. Mazzarino L. Di Pino G. Malaponte C. Porto G. Pennisi et. al. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test Vasc Med 8 1 2003 15-19
10. J. Constans M. Seigneur A.D. Blann B. Lestage F. Resplandy M. Renard et. al. Endothelial function, platelet activation and coagulation in lower limb occlusive arterial disease during treadmill exercise: Correlations with transcutaneous oxygen pressure Thromb Res 99 6 2000 557-561
11. U.J. Kirkpatrick M. Mossa A.D. Blann C.N. McCollum Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication Thromb Haemost 78 5 1997 1338-1342
12. G. Brevetti M. De Caterina V.D. Martone B. Ungaro F. Corrado A. Silvestro et. al. Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication Clin Hemorheol Microcirc 24 3 2001 193-199
13. L.C. Dunlop M.P. Skinner L.J. Bendall E.J. Favaloro P.A. Castaldi J.J. Gorman et. al. Characterization of GMP-140 (P-selectin) as a circulating plasma protein J Exp Med 175 4 1992 1147-1150
14. P. Harrison Platelet function analysis Blood Rev 19 2005 111-12315
15. S. Pasupathy K.M. Naseem S. Homer Vanniasinkam Effect of warm-up on exercise capacity, platelet activation and platelet-leucocyte aggregation in patients with claudication Br J Surg 92 2005 50-55
16. L. Macchi A. Brizard L. Christiaens D. Herpin Assessment of platelet activation after exercise using a standardized whole blood flow cytometry assay Thromb Res 106 2 2002 169-170
17. G.T.H. Lip A.D. Blann Von Willebrand factor and its relevance to cardiovascular disorders Br Heart J 74 1995 580-583
18. A.T. Edwards A.D. Blann V.J. Suarez-Mendez A.M. Lardi C.N. McCollum Systemic responses in patients with intermittent claudication after treadmill exercise Br J Surg 81 1994 1738-1741
19. D.R. Lewis A. Day J.Y. Jeremy R.N. Baird F.C. Smith P.M. Lamont The systemic effects of intermittent claudication are reversed by angioplasty Eur J Vasc Endovasc Surg 22 2001 326-330
20. S. Nawaz R.D. Walker C.H. Wilkinson J.M. Saxton A.G. Pockley R.F. Wood The inflammatory response to upper and lower limb exercise and the effects of exercise training in claudicants J Vasc Surg 33 2001 329
21. A.D. Pradham N. Rifai P.M. Ridker Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1 and the development of symptomatic peripheral arterial disease in men Circulation 106 2002 820-825
22. A. Silvestro F. Scopacasa G. Oliva T. de Cristofaro L. Iuliano G. Brevetti Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication Atherosclerosis 165 2002 277-283
23. J.W. Smith S.R. Steinhubl A.M. Lincoff J.C. Coleman T.T. Lee R.S. Hillman et. al. Rapid platelet-function assay: An automated and quantitative cartridge-based method Circulation 99 5 1999 620-625
24. S.R. Steinhubl J.D. Talley G.A. Braden et. al. Point of care measured platelet inhibition correlates with a reduced risk of an adverse event after percutaneous coronary intervention Circulation 103 2001 2572-2578
25. A. Malanin M. Spergling B. Muhlestein S. Steinbuhl V. Serebruany Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer Blood Coagul Fibrinolysis 15 2004 295-301
26. J.P. de la Cruz A. Guerrero J.A. Gonzalez-Correa E. Marquez I. Nacle F. Sanchez de la Cuesta Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans Eur J Clin Pharmacol 57 11 2002 775-780
27. T. Tekten C. Ceyhan E. Ercan A.O. Onbasili C. Turkoglu The effect of atorvastatin on platelet function in patients with coronary artery disease Acta Cardiol 59 3 2004 311-315
28. J. Coleman J.C. Wang D.I. Simon Determination of an individual response to aspirin therapy using the accumetrics Ultegra RPFA-ASSA system Point of care 2004 77-82
29. R. Rauramaa G. Li S.B. Vaisanen Dose-response and coagulation and hemostatic factors Med Sci Sports Exerc 33 2001 S516-S520 [see also p. 29]
30. U.M. Vischer C.B. Wollheim Epinephrine induces von Willebrand factor release from cultured endothelial cells: Involvement of cyclic AMP-dependent signalling in exocytosis Thromb Haemost 77 6 1997 1182-1188
31. P.T. Larsson N.H. Wallen A. Martinsson N. Egberg P. Hjemdahl Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro Thromb Haemost 68 6 1992 687-693
32. A.M. Malek S.L. Alper S. Izumo Hemodynamic shear stress and its role in atherosclerosis JAMA 282 21 1999 2035-2042
33. D.R. Riddell J.S. Owen Nitric oxide and platelet aggregation Vitam Horm 57 1999 25-48
34. M. Crowther I. Ford R.R. Jeffrey S.J. Urbaniak M. Greaves Quality of harvested autologous platelets compared with stored donor platelets for use after cardiopulmonary bypass procedures Br J Haematol 111 1 2000 175-181
35. C ollins P, F ord I, B all D, M acaulay E, G reaves M, B rittenden J. Surgery increases platelet aggregation in patients with severe limb ischaemia. Cochrane Database of Systematic Reviews (2):CD000990,2000.
36. M. Gawaz K. Brand T. Dickfield G. Pogatsa-Murray S. Page C. Bogner et. al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1 dependent mechanism Athersosclerosis 148 2000 75-85
37. M. Gawaz F.J. Neumann T. Dickfield W. Koch K.L. Laugwitz H. Adelsberger et. al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells Circulation 98 1998 1164-1171
38. R.D. Mc Bane 2nd K. Karnicki R.S. Miller W.G. Owen The impact of peripheral arterial disease on circulating platelets Thromb Res 113 2004 137-145
39. J. Yang B.C. Furie B. Furie The biolgy of P-selectin glycoprotein ligand-1: Its role as a selectin counterreceptor in leukocyte-endothelial and leucocyte-platelet interaction Thromb Haemost 81 1999 1-7
40. J.N. George E.B. Pickett S. Sauceman et. al. Platelet surface glycoproteins J Clin Invest 78 1986 340-348
41. M. Takano A. Meneshian E. Sheikh et. al. Rapid upregulation of endothelial P-selectin expression via reactive oxygen species generation Am J Physiol Heart Circ Physiol 283 2002 R1014-R1030
42. A.J. Broadley P. Gapper M. Schmitt M.P. Frenneaux Supine rest reduces platelet activation and aggregation Platelets 14 2003 3-7